Bridge Biotherapeutics, Inc. (KOSDAQ: 288330)
South Korea
· Delayed Price · Currency is KRW
4,060.00
-540.00 (-11.74%)
Dec 19, 2024, 3:00 PM KST
Bridge Biotherapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 18, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 170,610 | 80,182 | 277,059 | 333,876 | - | - | |
| Market Cap Growth | -9.67% | -71.06% | -17.02% | - | - | - | |
| Enterprise Value | 150,644 | 57,779 | 218,889 | 285,315 | - | - | |
| Last Close Price | 3940.00 | 2386.14 | 8425.95 | 10314.52 | 10568.76 | 13897.97 | |
| Forward PE | - | 9.41 | 9.41 | 9.41 | 9.41 | - | |
| PS Ratio | 87922.15 | 801.83 | 91.63 | 173.52 | - | - | |
| PB Ratio | 6.86 | 4.07 | 5.34 | 7.76 | - | - | |
| P/TBV Ratio | 4.56 | 6.03 | 5.61 | 7.79 | - | - | |
| EV/Sales Ratio | 84843.07 | 577.79 | 72.39 | 148.28 | - | - | |
| Debt / Equity Ratio | 0.10 | 0.18 | 0.06 | 0.01 | 0.01 | 0.00 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 0.15 | |
| Asset Turnover | 0.00 | 0.00 | 0.06 | 0.03 | 0.09 | 1.28 | |
| Quick Ratio | 4.37 | 2.01 | 6.97 | 12.23 | 56.55 | 15.34 | |
| Current Ratio | 4.56 | 2.09 | 7.33 | 12.49 | 57.14 | 16.72 | |
| Return on Equity (ROE) | -96.83% | -118.61% | -87.87% | -51.39% | -28.65% | 6.52% | |
| Return on Assets (ROA) | -42.41% | -53.58% | -50.30% | -29.95% | -17.08% | 0.84% | |
| Return on Capital (ROIC) | -50.28% | -64.55% | -55.40% | -32.06% | -18.15% | 1.50% | |
| Earnings Yield | -24.40% | -52.78% | -15.05% | -7.87% | - | - | |
| FCF Yield | -14.03% | -40.03% | -14.66% | -6.38% | - | - | |
| Buyback Yield / Dilution | -10.79% | -3.58% | -1.56% | -2.53% | -96.53% | -64.86% | |
| Total Shareholder Return | -10.79% | -3.58% | -1.56% | -2.53% | -96.53% | -64.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.